结核后肺疾病研究用病例定义
结核后肺疾病在研究中的定义差异大,影响证据比较与合成。作者在第2届国际结核后研讨会利益相关方意见基础上提出研究用病例定义,含既往肺结核或结核性胸膜炎且评估时无活动性结核、肺功能/呼吸症状/胸部影像三领域中至少两域异常、表现至少部分归因于既往结核三部分,并配报告框架。
要点
- 定义适用于研究场景,需与探索主要假设的研究特定定义并行使用而非替代。
- 三要素:既往肺结核或结核性胸膜炎且评估时无结核病;肺功能、呼吸症状、胸部影像三域中至少两域异常;表现至少部分归因于既往结核。
- 该定义基于共识与原则提出,缺乏长期患者结局数据,需随新证据演进。
核心结论
- 提出结核后肺疾病研究用病例定义以促进该领域定义统一与证据可比。
研究设计与样本
- 概念在第2届国际结核后研讨会经广泛利益相关方输入初步形成,会后由作者完善。
主要发现
- 结核幸存者长期肺功能损害负担受关注,但各研究对结核后肺疾病的定义差异显著。
关键数值与推荐
- 个体既往有肺结核或结核性胸膜炎,评估时无结核病。
- 评估时肺功能、呼吸症状、胸部影像三临床域中至少两域存在异常。
- 肺部疾病表现至少部分可归因于既往结核病。
临床怎么用
- 作为研究用定义,与探索主要假设的研究特定定义并行使用,并配套报告框架。
局限性
- 定义制定时缺乏长期患者结局数据,需随新证据演进。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite growing awareness of the substantial burden of long-term pulmonary impairment among tuberculosis survivors, marked variability in how post-tuberculosis lung disease is defined across research studies limits the comparison of findings and synthesis of evidence. To facilitate greater harmonisation within the field, we propose a case definition for post-tuberculosis lung disease for use in research studies. Conceptual aspects of this case definition were initially developed with input from a broad group of stakeholders at the 2nd International Post-Tuberculosis Symposium and were refined by the authors after the Symposium. Guiding principles for the definition include specificity, feasibility in settings with high tuberculosis disease burdens, probable relevance to long-term health outcomes, and applicability across the lifespan. The definition is designed to be used alongside, rather than instead of, study-specific definitions used to explore primary study hypotheses, and is accompanied by a reporting framework. The case definition has three components: that the individual had previous pulmonary or pleural tuberculosis disease and does not have tuberculosis disease at the time of evaluation; that the individual has, at the time of assessment, evidence of pulmonary disease with abnormalities in at least two of three clinical domains of lung function, respiratory symptoms, and chest imaging; and that the pulmonary disease manifestations should be attributable at least in part to previous tuberculosis disease. This definition is developed in the absence of data on long-term patient outcomes and will need to evolve over time in response to emerging evidence. However, we believe this proposed definition will lead to greater consistency and rigor across studies of post-tuberculosis lung disease with the goal of improving care and quality of life for millions of tuberculosis survivors worldwide.
引用
- Bisson GP, Allwood B, Byrne A, et al. Post-tuberculosis lung disease: a case definition for use in research studies. Lancet Infect Dis. 2025. PMID: 41232546. doi:10.1016/S1473-3099(25)00548-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。